<DOC>
	<DOCNO>NCT00357331</DOCNO>
	<brief_summary>Skeletal buffering chronic acid load may contribute significant amount bone loss time . Evidence small short-term study suggest basic compound , namely potassium citrate potassium bicarbonate may reduce bone loss improve bone density . The purpose study evaluate effect potassium citrate bone metabolism . We hypothesize administration potassium citrate postmenopausal woman osteopenia reduce bone resorption improve bone mineral density . Postmenopausal woman osteopenia ( T score -1.0 -2.5 ) history fracture randomize either daily potassium citrate placebo one year . Primary outcomes marker bone turnover , measure 12 month . Secondary outcome bone mineral density , compliance , adverse event .</brief_summary>
	<brief_title>The Effects Potassium Citrate Bone Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Postmenopausal woman , 2 year post menopause Osteopenia , define T score lumbar spine total hip 1.0 2.5 No history prior fragility fracture Exclusion criterion : Renal insufficiency Use potassium spar diuretic Use potassium supplement Hyperkalemia Secondary cause osteoporosis metabolic bone disease Delayed gastric empty esophageal compression , intestinal obstruction stricture use anticholinergic medication active urinary tract infection .</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>postmenopausal osteopenia</keyword>
	<keyword>treatment</keyword>
	<keyword>bone loss</keyword>
</DOC>